The basic objective

To develop avant-garde control measures against vector-borne diseases

Disease

Vector borne diseases transmitted by daytime active mosquitos put a high health burden on the society

Control

Insecticides and repellents are available but hard to administer in an environmentally sustainable way

Nanoparticles

Use micro- and nanoparticles to release insecticides and repellents in a well controlled dosage

Overview

IMAAC aims at investigation and mathematical analysis of the effect of avant-garde control measures in vector-borne diseases involving day-time active mosquitos transmitting diseases like dengue, Zika, chikungunya and yellow fever. The control measures involve new technologies in textile and paint products based on nano- and micro-particles releasing repellents or pesticides in well portioned dosage. The study will also be expanded to scenarios using vaccines in combination with mentioned control techniques. The main focus will be on dengue fever transmitted via Aedes aegypti and Aedes albopictus mosquitoes in synergy with existing EU-projects, but the application will have also positive effects on other vector-borne diseases.

Nano- and micro-particles are used in textile production for various purposes, and can be used to release chemicals like repellents and insecticides in a well-controlled rate. First attempts in this direction have been made, but no efficacy studies could be performed yet. The spectrum of combinations of nano- or micro-particles, repellents, insecticides and types of textiles (or paint) has not been well studied. Especially, efficacy studies in cases using these control measures in combination with vaccines are unchartered territories and mathematical modelling has to be developed.

This Action aims to bring together experts from epidemiology, biostatistics, mathematics, biology, nano-technology, chemical and textile engineering to implement new techniques to combat mosquito transmitted vector-borne diseases. The key question remains, in how far such avant-garde measures can help to reduce the disease burden, eventually in collaboration with existing vaccines which turned out to have only limited efficacy on their own.

News

The latest news

Get in Touch

If you want to join this COST Action, please get in contact with...

Find us at the office

Give us a ring

Contact Us